Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine.
Circ J. 2013;77(9):2209-17. doi: 10.1253/circj.cj-13-0971. Epub 2013 Aug 14.
Heart failure (HF) is a global epidemic in health care and a leading cause of mortality and morbidity worldwide. In Asian countries, causes of mortality and morbidity have shifted or have been shifting from infectious diseases and/or nutritional deficiencies to lifestyle-related diseases, such as cardiovascular disease, cancers and diabetes, in conjunction with the transition from developing to developed countries during the past decades (so-called "the epidemiologic transition"). Because the effect of this epidemiologic transition varies among countries, the etiology, prevalence, management and outcomes of HF also differ among the countries. Thus, we need to assemble and comprehensively analyze the available evidence to date for daily HF practice in Asia and to systematically conduct future epidemiologic approaches to establishing appropriate prevention programs against the burden of HF in Asia. This review article will briefly update the epidemiology of HF in Asia.
心力衰竭(HF)是全球医疗保健领域的一个全球性流行疾病,也是全球死亡和发病的主要原因。在亚洲国家,死亡率和发病率的原因已经从传染病和/或营养缺乏转变为与生活方式相关的疾病,如心血管疾病、癌症和糖尿病,同时在过去几十年中,这些国家也从发展中国家向发达国家过渡(所谓的“流行病学转变”)。由于这种流行病学转变的影响在各国之间有所不同,因此 HF 的病因、流行程度、管理和结果在各国之间也有所不同。因此,我们需要收集和全面分析迄今为止亚洲 HF 日常实践的现有证据,并系统地开展未来的流行病学方法,以制定针对亚洲 HF 负担的适当预防计划。本文将简要更新亚洲 HF 的流行病学。